Back to Search
Start Over
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
- Source :
-
Annals of surgical oncology [Ann Surg Oncol] 2023 Mar; Vol. 30 (3), pp. 1889-1890. Date of Electronic Publication: 2022 Dec 23. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 1534-4681
- Volume :
- 30
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Annals of surgical oncology
- Publication Type :
- Report
- Accession number :
- 36564654
- Full Text :
- https://doi.org/10.1245/s10434-022-12877-3